Eating
Bulimia Nervosa
search
Bulimia Nervosa
, Bulimia
See Also
Eating Disorder
Anorexia Nervosa
Avoidant-Restrictive Food Intake Disorder
(
ARFID
)
Epidemiology
Onset in adolescence or early adulthood
Prevalence
: 4-6 per 200 females in U.S. (much more common than
Anorexia
)
Affects women much more than men by ratio of 10-20:1
Risk Factors
Similar personality traits as with
Anorexia Nervosa
(common to other
Eating Disorder
s)
Perfectionist, high achiever, who values success and external rewards
Food and appearance regulation is under their control
Sexual Assault
or sexual abuse
Increases Bulimia risk
Symptoms
Bloating or abdominal fullness
Sensation
Gastroesophageal Reflux
disease
Abdominal Pain
Pharyngitis
Severe
Constipation
(withdrawal from
Laxative
s)
Behaviors to control weight
Binge Eating
Purging (induced
Vomiting
,
Laxative
use,
Diuretic
s)
Establishes elaborate schedules to allow for
Binge Eating
, purging and frequent bathroom use
Excessive
Exercise
Signs
Disordered eating and distorted body image
See DSM IV Diagnosis below
Patients are most often of normal weight
Contrast with under-weight in
Anorexia Nervosa
Weight in Bulimia tends to fluctuate
Poor impulse control
Physical signs of Bulimia
Callused knuckles (Russell Sign)
Dental enamel erosions and
Gingivitis
Salivary Gland
hypertrophy (esp.
Parotid Gland
)
Mallory-Weiss Tear (from forceful
Vomiting
)
Edema
Evaluation Tools
See
SCOFF Questionnaire
Diagnosis
DSM V
Major Criteria
Recurrent
Binge Eating
Eating more than most people eat per time period (e.g. 2 hours)
Perceived lack of control during eating episode (unable to stop eating)
Recurrent compensatory behaviors to prevent weight gain
Purging
Self-induced
Vomiting
Medication misuse (see purging behavior above)
Diet pills
Laxative
s or enemas
Diuretic
s
Other inappropriate weight loss control
Fastin
g
Excessive
Exercise
Binging and weight loss on average at least weekly over 3 months
Overconcern with body shape and weight
Episodes not limited to
Anorexia Nervosa
episodes
Subtypes
Purging Type
Regular, ongoing purging behaviors (see above)
Non-purging type
No purging behaviors
Weight controlled with
Fastin
g, excessive
Exercise
Remission Criteria
Partial Remission
Previously met full major criteria for Bulimia
Now meets some, but not all Bulimia criteria for a sustained period of time
Full Remission
Previously met full major criteria for Bulimia
Now meets none of the major criteria for Bulimia for a sustained period of time
Severity (for adults, use BMI percentiles for children and adolescents)
Mild
An average of 1-3 episodes of inappropriate compensatory behaviors weekly
Moderate
An average of 4-7 episodes of inappropriate compensatory behaviors weekly
Severe
An average of 8-13 episodes of inappropriate compensatory behaviors weekly
Extreme
An average of 14 or more episodes of inappropriate compensatory behaviors weekly
References
(2013) DSM V, APA, Washington
Associated Conditions
Female Athlete Triad
Oligomenorrhea
(50% of cases)
No associated bone loss (contrast with
Anorexia
)
Weight bearing
Exercise
protective of bone in Bulimia
Psychiatric illness
See
Anorexia
Personality Disorder
(confers worse prognosis)
Cluster B - dramatic, erratic
Borderline Personality Disorder
Narcissistic Personality
Disorder
Antisocial Personality
Disorder
Self deprecation and low self esteem
Major Depression
with suicidal ruminations
Anxiety Disorder
Risk-taking behaviors
Substance Abuse
Unprotected sexual activity
Self mutilation
Differential Diagnosis
See
Anorexia
Labs
Complete Blood Count
Leukopenia
Comprehensive Metabolic Panel (changes related to purging)
Hypochloremic
Metabolic Alkalosis
Hypokalemia
Serum Amylase
May be increased with induced
Vomiting
Serum
Lipase
is often normal
Humphries (1987) Ann Intern Med 106(1):50-2 +PMID:2431640 [PubMed]
Serum Phosphorus
Serum Magnesium
Thyroid Stimulating Hormone
Urinalysis
Increased
Urine Specific Gravity
Increased
Urine Ketone
s
Decreased
Urine pH
Diagnostics
Electrocardiogram
Same as in
Anorexia
Management
Inpatient Indications
Suicidal Ideation
with plan
Intractable
Vomiting
Hematemesis
Mallory-Weiss Tear (
Esophageal Tear
)
Syncope
Prolonged QT
c or
Cardiac Arrhythmia
Serum Potassium
<3.2 mg/dl
Serum Chloride
<88 mg/dl
Hypothermia
Failed outpatient management
References
Campbell (2014) Pediatrics 134(3): 582-92 [PubMed]
Management
Gene
ral
Hypokalemia
management if present
Prevention of secondary complications
Fluoridated Mouthwash and
Tooth
paste
Sour candy to decrease
Salivary Gland
swelling
Antacid
medications for
Reflux Esophagitis
Management
Psychiatric
Cognitive behavior therapy
Cognitive behavior therapy is first line management
Effective in only 40 to 50% of bulimic patients
Indications to consider alternative therapy
Purging not reduced 70% by sixth session
Antidepressant
agents are effective adjuncts to therapy
Venlafaxine
(
Effexor
)
Fluoxetine
Titrate to 60 mg orally daily over 2 to 3 weeks
Other
Selective Serotonin Reuptake Inhibitor
s (
SSRI
)
Avoid
Wellbutrin
(
Seizure
risk)
Other medications
Topiramate
May decrease
Binge Eating
, but also risks
Cognitive Impairment
while on the medication
Management
Oligomenorrhea
History and physical examination
Consistent with
Anovulation
Laboratory evaluation for significant
Oligomenorrhea
Urine Pregnancy Test
Luteinizing Hormone
(LH)
Follicle Stimulating Hormone
(FSH)
Thyroid Stimulating Hormone
(TSH)
Prolactin
Total Testosterone
and
Free Testosterone
Consider
Serum Dehydroepiandrosterone
sulfate level
Indicated for signs of androgenization
Suspected
Unopposed Estrogen
management
Patient characteristics
Normal weight patient
Anovulation
Elevated androgen levels
Withdrawal bleed after
Provera
10 mg x7 days trial
Protocol for
Endometrial Cancer
prevention
Provera
10 mg qd for 7 days repeated q3 months or
Oral Contraceptive
cycling
Prognosis
Remission rate with treatment: 80%
Relapse rate: 20%
All-cause mortality relative ratio: 1.6-1.9
Resources
Jackson (1991) Dieting: Dry Drunk- Dieting Recovery
References
(1994) DSM IV, APA, p. 544-5
Renbarger and Pearson (2021) Crit Dec Emerg Med 35(8): 17-23
Agras (2000) Am J Psychiatry 157:1302-8 [PubMed]
Harrington (2014) Am Fam Physician 91(1): 46-52 [PubMed]
Klein (2021) Am Fam Physician 103(1): 22-32 [PubMed]
McGilley (1998) Am Fam Physician, 57(11): 2743-50 [PubMed]
Mehler (2003) N Engl J Med 349:875-81 [PubMed]
Seidenfeld (2001) Am Fam Physician 64(3):445-50 [PubMed]
Sundgot-Borgen (1998) J Clin Endocrinol Metab 83:3144-9 [PubMed]
Walsh (2004) Am J Psychiatry 161:556-61 [PubMed]
Yanovski (1991) Am Fam Physician, 44(4): 1231-38 [PubMed]
Type your search phrase here